Tau is essential to β-amyloid-induced neurotoxicity
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Senile plaques and neurofibrillary tangles, the two hallmark lesions of Alzheimer's disease, are the results of the pathological deposition of proteins normally present throughout the brain. Senile plaques are extracellular deposits of fibrillar β-amyloid peptide (Aβ); neurofibrillary tangles represent intracellular bundles of self-assembled hyperphosphorylated tau proteins. Although these two lesions are often present in the same brain areas, a mechanistic link between them has yet to be established. In the present study, we analyzed whether tau plays a key role in fibrillar Aβ-induced neurite degeneration in central neurons. Cultured hippocampal neurons obtained from wild-type, tau knockout, and human tau transgenic mice were treated with fibrillar Aβ. Morphological analysis indicated that neurons expressing either mouse or human tau proteins degenerated in the presence of Aβ. On the other hand, tau-depleted neurons showed no signs of degeneration in the presence of Aβ. These results provide direct evidence supporting a key role for tau in the mechanisms leading to Aβ-induced neurodegeneration in the central nervous system. In addition, the analysis of the composition of the cytoskeleton of tau-depleted neurons suggested that the formation of more dynamic microtubules might confer resistance to Aβ-mediated neurodegeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These observations support the idea that Aβ and Tau act together and that Aβ is upstream of Tau [114,115], positioning Aβ as the initiator and Tau as the executor in the pathogenetic process [116].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [115]
In the citing paper
“Indeed, Tau has been implicated in the synaptotoxicity induced by Aβ exposure [102].”
From The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? (2019) · cites this paper as [102]
In the citing paper
“Thus, cultured neurons from tau knockout (Tau−/−) mice are not susceptible to Aβ-induced synaptic damage and neurotoxicity (Rapoport et al., 2002; Nussbaum et al., 2012; Zempel et al., 2013) or to Aβ-induced defects in axonal transport (Vossel et al., 2011).”
From Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau−/− mice (2017) · cites this paper as Rapoport et al., 2002
In the citing paper
“Neurons without tau are resistant to Aβ toxicity, and APP transgenic mice lacking tau develop Aβ pathology but remain cognitively normal (Rapoport et al., 2002; Roberson et al., 2007).”
From CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer’s Disease (2018) · cites this paper as Rapoport et al., 2002
In the citing paper
“Data from cell and animal models show that tau is also a mediator of Aβ-induced toxicity46–48.”
From Tau-targeting therapies for Alzheimer disease (2018) · cites this paper as [46]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Assay of proteins in the presence of interfering materials
Bensadoun, A., & Weinstein, D. (1976) · Analytical Biochemistry · doi:10.1016/s0003-2697(76)80064-4 · Cited by 3,179
Growth of a rat neuroblastoma cell line in serum-free supplemented medium.
Bottenstein, J. E., & Sato, G. H. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.514 · Cited by 2,276
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,778
Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,459
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Research works printed but not linked: 2
- M P Vitek, C G Rasool, F de Sauvage, S M Vitek, R T Bartus, B Beer, R A Ashton, A F Macq, J M Maloteaux, A J Blume Brain Res 464, 121–131 (1988).
- J G Wood, S S Mirra, N L Pollock, L I Binder Proc Natl Acad Sci USA 508, 320–324 (1986).
Cited by
Items 201–300 of 971
Kim, S., Choi, K. J., Cho, S.-J., Yun, S.-M., Jeon, J.-P., Koh, Y. H., Song, J., Johnson, G. V. W., & Jo, C. (2016) · Scientific Reports · doi:10.1038/srep24933 · Cited by 114
Ding, H., Matthews, T. A., & Johnson, G. V. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511697200 · Cited by 114
Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease
Bulic, B., Pickhardt, M., & Mandelkow, E. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3017317 · Cited by 114
Jiang, S., & Bhaskar, K. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.586731 · Cited by 114
ACAT1/SOAT1 as a Therapeutic Target for Alzheimer's Disease
Shibuya, Y., Chang, C. C., & Chang, T.-Y. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.161 · Cited by 113
Ferreira, A., & Bigio, E. H. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00220 · Cited by 112
Self-citationTau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits
de Barreda, E. G., Pérez, M., Ramos, P. G., de Cristobal, J., Martín-Maestro, P., Morán, A., Dawson, H. N., Vitek, M. P., Lucas, J. J., Hernández, F., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.017 · Cited by 112
Self-citationTsitsopoulos, P. P., & Marklund, N. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00079 · Cited by 111
O‐GlcNAcylation: A regulator of tau pathology and neurodegeneration
Gong, C., Liu, F., & Iqbal, K. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.011 · Cited by 111
Microglia-Astrocyte Communication in Alzheimer’s Disease
Wu, Y., & Eisel, U. L. M. (2023) · Journal of Alzheimer’s Disease · doi:10.3233/jad-230199 · Cited by 111
Synaptic targeting by Aβ oligomers (ADDLS) as a basis for memory loss in early Alzheimer's disease
Klein, W. L. (2006) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.11.003 · Cited by 110
Rush, T., Martinez-Hernandez, J., Dollmeyer, M., Frandemiche, M. L., Borel, E., Boisseau, S., Jacquier-Sarlin, M., & Buisson, A. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.1409-18.2018 · Cited by 110
Microtubule Dynamics in Neuronal Development, Plasticity, and Neurodegeneration
Penazzi, L., Bakota, L., & Brandt, R. (2015) · International review of cytology · doi:10.1016/bs.ircmb.2015.09.004 · Cited by 110
Delineating the Mechanism of Alzheimer’s Disease Aβ Peptide Neurotoxicity
Cappai, R., & Barnham, K. J. (2008) · Neurochemical Research · doi:10.1007/s11064-007-9469-8 · Cited by 108
Hernandez, P., Lee, G., Sjoberg, M., & Maccioni, R. B. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0933 · Cited by 107
“This is consistent with the Aβinduced activation of Fyn as previously reported [15] and the positioning of Fyn and tau in signal transduction pathways activated by Aβ [36,37].”
Nicholson, A. M., & Ferreira, A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0862-09.2009 · Cited by 106
Self-citationTau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma
Chiasseu, M., Cueva Vargas, J. L., Destroismaisons, L., Vande Velde, C., Leclerc, N., & Di Polo, A. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3986-15.2016 · Cited by 105
Kumar, N., Kumar, V., Anand, P., Kumar, V., Dwivedi, A. R., & Kumar, V. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116742 · Cited by 105
The Exceptional Vulnerability of Humans to Alzheimer’s Disease
Walker, L. C., & Jucker, M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.04.001 · Cited by 104
Li, H., Liu, C.-C., Zheng, H., & Huang, T. Y. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0139-3 · Cited by 103
Yu, W., Polepalli, J., Wagh, D., Rajadas, J., Malenka, R., & Lu, B. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr576 · Cited by 103
Vitek, M. P., Araujo, J. A., Fossel, M., Greenberg, B. D., Howell, G. R., Rizzo, S. J. S., Seyfried, N. T., Tenner, A. J., Territo, P. R., Windisch, M., et al. (2020) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12114 · Cited by 103
Self-citationAmadoro, G., Corsetti, V., Atlante, A., Florenzano, F., Capsoni, S., Bussani, R., Mercanti, D., & Calissano, P. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.001 · Cited by 103
Slow Excitotoxicity in Alzheimer's Disease
Ong, W.-Y., Tanaka, K., Dawe, G. S., Ittner, L. M., & Farooqui, A. A. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-121990 · Cited by 100
Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriers
Caselli, R. J., Dueck, A. C., Locke, D. E. C., Hoffman-Snyder, C. R., Woodruff, B. K., Rapcsak, S. Z., & Reiman, E. M. (2011) · Neurology · doi:10.1212/wnl.0b013e3182167147 · Cited by 98
Ravula, A. R., Teegala, S. B., Kalakotla, S., Pasangulapati, J. P., Perumal, V., & Boyina, H. K. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174492 · Cited by 98
Michaelis, M. L., Ansar, S., Chen, Y., Reiff, E. R., Seyb, K. I., Himes, R. H., Audus, K. L., & Georg, G. I. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.074450 · Cited by 98
Zhang, W., Kandel, N., Zhou, Y., Smith, N. S., Ferreira, B. C. L. B., Perez, M., Claure, M. L., Mintz, K. J., Wang, C., & Leblanc, R. M. (2022) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2022.02.124 · Cited by 98
Sotiropoulos, I., Catania, C., Riedemann, T., Fry, J. P., Breen, K. C., Michaelidis, T. M., & Almeida, O. F. X. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05613.x · Cited by 97
“…in GC-induced toxicity, and given that tau protein seems essential for the manifestation of the toxic actions of stimuli such as kainate and Ab (Rapoport et al. 2002; Roberson et al. 2007), we sought to compare the 2008 The Authors Journal Compilation 2008 International Society for…”
BackgroundSerum Tau Proteins as Potential Biomarkers for the Assessment of Alzheimer’s Disease Progression
Nam, E., Lee, Y.-B., Moon, C., & Chang, K.-A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145007 · Cited by 97
Iijima, K., Gatt, A., & Iijima-Ando, K. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq200 · Cited by 96
Stefanova, N., Kozhevnikova, O., Vitovtov, A., Maksimova, K., Logvinov, S., Rudnitskaya, E., Korbolina, E., Muraleva, N., & Kolosova, N. (2014) · Cell Cycle · doi:10.4161/cc.28255 · Cited by 96
Park, S.-Y., Tournell, C. E., Sinjoanu, R. C., & Ferreira, A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.012 · Cited by 96
Self-citationIn vivo mapping of amyloid toxicity in Alzheimer disease
Frisoni, G. B., Lorenzi, M., Caroli, A., Kemppainen, N., Någren, K., & Rinne, J. O. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a2e896 · Cited by 96
Axonal Degeneration in AD: The Contribution of Aβ and Tau
Salvadores, N., Gerónimo-Olvera, C., & Court, F. A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.581767 · Cited by 96
Pérez, M., Ribé, E. M., Rubio, A., Lim, F., Morán, M. A., Gómez‐Ramos, P., Ferrer, I., Isla, M. T. G., & Ávila, J. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.029 · Cited by 94
Exosomes and microRNAs: New potential therapeutic candidates in Alzheimer disease therapy
Iranifar, E., Seresht, B. M., Momeni, F., Fadaei, E., Mehr, M. H., Ebrahimi, Z., Rahmati, M., Kharazinejad, E., & Mirzaei, H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27214 · Cited by 93
Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease
Rosa, E., Mahendram, S., Ke, Y. D., Ittner, L. M., Ginsberg, S. D., & Fahnestock, M. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.020 · Cited by 92
Do, T. D., Economou, N. J., Chamas, A., Buratto, S. K., Shea, J., & Bowers, M. T. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp506258g · Cited by 92
Xian, Y., Lin, Z.-X., Mao, Q., Hu, Z. J., Zhao, M., Che, C., & Ip, S. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/802625 · Cited by 92
Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration
Duan, Y., Dong, S., Gu, F., Hu, Y., & Zhao, Z. (2012) · Translational Neurodegeneration · doi:10.1186/2047-9158-1-24 · Cited by 92
Loss of tau rescues inflammation-mediated neurodegeneration
Maphis, N., Xu, G., Kokiko-Cochran, O. N., Cardona, A. E., Ransohoff, R. M., Lamb, B. T., & Bhaskar, K. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00196 · Cited by 91
“First, tau-deficient neurons have been shown to be resistant to Aβ-mediated neurotoxicity (Rapoport et al., 2002).”
BackgroundAlzheimer's Disease and Amyloid: Culprit or Coincidence?
Skaper, S. D. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00011-9 · Cited by 91
CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer’s Disease
Shentu, Y.-P., Huo, Y., Feng, X.-L., Gilbert, J., Zhang, Q., Liuyang, Z.-Y., Wang, X.-L., Wang, G., Zhou, H., Wang, X.-C., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.009 · Cited by 90
Age-related diseases as vicious cycles
Belikov, A. V. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2018.11.002 · Cited by 90
Genetic ablation of tau improves mitochondrial function and cognitive abilities in the hippocampus
Jara, C., Aránguiz, A., Cerpa, W. F., Tapia‐Rojas, C., & Quintanilla, R. A. (2018) · Redox Biology · doi:10.1016/j.redox.2018.07.010 · Cited by 90
The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
Pritchard, S. M., Dolan, P. J., Vitkus, A., & Johnson, G. V. W. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01273.x · Cited by 89
Kodis, E. J., Choi, S., Swanson, E., Ferreira, G., & Bloom, G. S. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.05.017 · Cited by 89
Usardi, A., Pooler, A. M., Seereeram, A., Reynolds, C. H., Derkinderen, P., Anderton, B., Hanger, D. P., Noble, W., & Williamson, R. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08218.x · Cited by 89
Brandt, R., Trushina, N. I., & Bakota, L. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.590059 · Cited by 89
Saul, A., Sprenger, F., Bayer, T. A., & Wirths, O. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.003 · Cited by 88
Emerging Therapeutics for Alzheimer's Disease
Chiang, K., & Koo, E. H. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135932 · Cited by 88
Leuba, G., Walzer, C., Vernay, A., Carnal, B., Kraftsik, R., Piotton, F., Marin, P., Bouras, C., & Savioz, A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.012 · Cited by 88
Nie, C. L., Yan, W., Chen, X., Liu, Y. Y., Dui, W., Liu, Y. M., Davies, M. C., Tendler, S. J. B., & He, R. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000629 · Cited by 88
Application of Surface-Enhanced Raman Spectroscopy for Detection of Beta Amyloid Using Nanoshells
Beier, H. T., Cowan, C. B., Chou, I.-H., Pallikal, J., Henry, J. E., Benford, M. E., Jackson, J. B., Good, T. A., & Coté, G. L. (2007) · Plasmonics · doi:10.1007/s11468-007-9027-x · Cited by 88
Tau Aggregates: Toxic, Inert, or Protective Species?
Bretteville, A., & Planel, E. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-14411 · Cited by 87
Liu, T., Perry, G., Chan, H. W., Verdile, G., Martins, R. N., Smith, M. A., & Atwood, C. S. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02196.x · Cited by 86
Endogenous Aβ causes cell death via early tau hyperphosphorylation
Amadoro, G., Corsetti, V., Ciotti, M. T., Florenzano, F., Capsoni, S., Amato, G., & Calissano, P. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.06.005 · Cited by 86
Potential therapeutic agents against Alzheimer’s disease from natural sources
Park, S. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-1010-y · Cited by 86
The Impact of Estradiol on Neurogenesis and Cognitive Functions in Alzheimer’s Disease
Negah, S. S., Hajali, V., Moradi, H. R., & Gorji, A. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00733-0 · Cited by 86
Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons
Kelly, B. L., & Ferreira, A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.03.047 · Cited by 85
Self-citationGötz, J., Xia, D., Leinenga, G., Chew, Y. L., & Nicholas, H. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00072 · Cited by 85
Eph receptors at synapses: Implications in neurodegenerative diseases
Chen, Y., Fu, A. K. Y., & Ip, N. Y. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.11.016 · Cited by 85
Vieira, M. N. N., Forny‐Germano, L., Saraiva, L. M., Sebollela, A., Martinez, A. M. B., Houzel, J., De Felice, F. G., & Ferreira, S. T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04809.x · Cited by 85
Zhang, D., Zhang, W., Chen, M., Gao, X., Yuan, H., Lin, X., Mao, X., Wang, C., Guo, X., Du, Y., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.02.017 · Cited by 84
Recent Progress in Alzheimer’s Disease Research, Part 1: Pathology
Hane, F. T., Lee, B. Y., & Leonenko, Z. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160882 · Cited by 84
Folwell, J., Cowan, C. M., Ubhi, K. K., Shiabh, H., Newman, T. A., Shepherd, D., & Mudher, A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.014 · Cited by 83
Modes of Aβ toxicity in Alzheimer’s disease
Götz, J., Eckert, A., Matamales, M., Ittner, L. M., & Liu, X. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0750-2 · Cited by 83
Musiek, E. S., & Holtzman, D. M. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835a30f4 · Cited by 82
Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer’s Disease
Pérez, M. J., Vergara-Pulgar, K., Jara, C., Cabezas-Opazo, F., & Quintanilla, R. A. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0385-x · Cited by 81
Tau accumulation triggers STAT1‐dependent memory deficits by suppressing NMDA receptor expression
Li, X., Hong, X., Wang, Y., Zhang, S., Zhang, J., Li, X., Liu, Y., Sun, D., Feng, Q., Ye, J., et al. (2019) · The EMBO Reports · doi:10.15252/embr.201847202 · Cited by 81
Granic, A., Padmanabhan, J., Norden, M., & Potter, H. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-10-0850 · Cited by 81
Calviello, G., Su, H.-M., Weylandt, K. H., Fasano, E., Serini, S., & Cittadini, A. (2013) · BioMed Research International · doi:10.1155/2013/743171 · Cited by 81
Hypothesis for a Common Basis for Neuroprotection in Glaucoma and Alzheimer's Disease
Tatton, W. G., Chen, D., Chalmers-Redman, R. M. E., Wheeler, L. A., Nixon, R. A., & Tatton, N. A. (2003) · Survey of Ophthalmology · doi:10.1016/s0039-6257(03)00005-5 · Cited by 81
Flachbartova, Z., & Kováčech, B. (2013) · Acta Virologica · doi:10.4149/av_2013_01_3 · Cited by 81
Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy
Ye, J., Wan, H., Chen, S., & Liu, G. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385847 · Cited by 80
Reifert, J., Hartung-Cranston, D., & Feinstein, S. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.234674 · Cited by 80
Role of Tau Protein in Neuronal Damage in Alzheimer's Disease and Down Syndrome
Cárdenas, A. M., Ardiles, Á. O., Barraza, N., Báez‐Matus, X., & Caviedes, P. A. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.10.012 · Cited by 80
Microtubule dynamics and the neurodegenerative triad of Alzheimer's disease: The hidden connection
Brandt, R., & Bakota, L. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14011 · Cited by 80
Zuo, Z., Qi, F., Yang, J., Wang, X., Wu, Y., Wen, Y., Yuan, Q., Zou, J., Guo, K., & Yao, Z. B. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.02.001 · Cited by 80
Drugs targeting alzheimer’s disease: Some things old and some things new
Michaelis, M. L. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035840 · Cited by 78
“In addition, neurons from knockout mice show no significant degeneration in the presence of A (Rapoport et al., 2002).”
BackgroundRoles of p75NTR in the pathogenesis of Alzheimer's disease: A novel therapeutic target
Zeng, F., Lu, J., Zhou, X., & Wang, Y. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.040 · Cited by 78
Datki, Z., Papp, R., Zádori, D., Soós, K., Fülöp, L., Juhász, A., Laskay, G., Hetényi, C., MIHALIK, E., Zarándi, M., et al. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.08.007 · Cited by 78
Amyloid-β and Tau Pathology of Alzheimer's Disease Induced by Diabetes in a Rabbit Animal Model
Bitel, C. L., Kasinathan, C., Kaswala, R. H., Klein, W. L., & Frederikse, P. H. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120571 · Cited by 78
Fernandes, C., Paya‐Cano, J. L., Sluyter, F., D'Souza, U., Plomin, R., & Schalkwyk, L. C. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03358.x · Cited by 78
The genetics of neurodegenerative diseases
Hardy, J., & Orr, H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03979.x · Cited by 78
Gong, C.-X., Liu, F., Grundke-Iqbal, I., & Iqbal, K. (2006) · BioMed Research International · doi:10.1155/jbb/2006/31825 · Cited by 78
Persistent repression of tau in the brain using engineered zinc finger protein transcription factors
Wegmann, S., DeVos, S. L., Zeitler, B., Marlen, K., Bennett, R. E., Perez-Rando, M., MacKenzie, D., Yu, Q., Commins, C., Bannon, R. N., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe1611 · Cited by 77
δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities
Zhang, Z., Tian, Y., & Ye, K. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-019-0179-3 · Cited by 77
Largo-Barrientos, P., Apóstolo, N., Creemers, E., Callaerts-Vegh, Z., Swerts, J., Davies, C., McInnes, J., Wierda, K., De Strooper, B., Spires-Jones, T., et al. (2021) · Neuron · doi:10.1016/j.neuron.2020.12.016 · Cited by 77
Sigurdsson, E. M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179937 · Cited by 76
Kanno, T., Tsuchiya, A., & Nishizaki, T. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.034 · Cited by 76
Emerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders
Torres, V. I., Vallejo, D., & Inestrosa, N. C. (2017) · Neural Plasticity · doi:10.1155/2017/8081758 · Cited by 76
Ota, M., Sato, N., Nakaya, M., Shigemoto, Y., Kimura, Y., Chiba, E., Yokoi, Y., Tsukamoto, T., & Matsuda, H. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-220534 · Cited by 76
AMPA Receptor Trafficking in Natural and Pathological Aging
Jurado, S. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00446 · Cited by 76
Martin, L., Magnaudeix, A., Esclaire, F., Yardin, C., & Terro, F. (2008) · Brain Research · doi:10.1016/j.brainres.2008.11.057 · Cited by 76
Mueller, R. L., Combs, B., Alhadidy, M. M., Brady, S. T., Morfini, G. A., & Kanaan, N. M. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.647054 · Cited by 76
Small-molecule BACE1 inhibitors: a patent literature review (2006 – 2011)
Probst, G., & Xu, Y.-Z. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.681302 · Cited by 76
TOC1: Characterization of a Selective Oligomeric Tau Antibody
Ward, S. M., Himmelstein, D. S., Lancia, J. K., Fu, Y., Patterson, K. R., & Binder, L. I. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-131235 · Cited by 76
Self-citationNeuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models
Wirths, O., & Zampar, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218144 · Cited by 75
Metadata
- Authors
- Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A.
- Affiliations
- Northwestern University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-04-16
- Volume
- 99
- Issue
- 9
- Pages
- 6364-6369
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC122954
- OpenAlex
- W2081768153
- Cited by
- 807
- References
- 45
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 22 · 2023: 24 · 2022: 22 · 2021: 25 · 2020: 44 · 2019: 37 · 2018: 40 · 2017: 43 · 2016: 39 · 2015: 40 · 2014: 55 · 2013: 44 · 2012: 51
- FWCI
- 15.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag015383-02)
- National Institute on Aging (AG15383)
- National Institute of Neurological Disorders and Stroke (R01NS039080, NS 39080)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- tau protein, amyloid-beta, Alzheimer's disease, neurotoxicity, neurite degeneration, hippocampal neurons, microtubules, cytoskeleton, amyloid plaques, neurofibrillary tangles, amyloid fibrils
- MeSH terms
- Animals, Brain, Central Nervous System, Cytoskeleton, Hippocampus, Humans, Immunohistochemistry, Mice, Transgenic, Microtubules, Phenotype, Immunoblotting, Blotting, Western, Amyloid beta-Peptides, tau Proteins, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.